Dinoprostone
Who holds supplier records for Dinoprostone? 5 organisations hold a current record for Dinoprostone: an active US FDA Type II Drug Master File or a CEP. A further 1 organisation has only historical (inactive) DMF filings. 2 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: Japan (1), China (1), Taiwan (1), Hungary (1) and 1 other country (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Dinoprostone: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/dinoprostone
Reading the evidence
- 5 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 1 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (5)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Dinoprostone. Country is the organisation's recorded country, not necessarily the manufacturing site.
- KYOWA PHARMA CHEMICAL CO LTDJapanCEP Company GMP cert on recordActive DMF 41392, 11274 · latest filing Mar 2025
- TIEN (Tianjin) Pharmaceutical Co. LtdChinaCEPActive DMF 42261 · latest filing Jul 2025
- CHIROGATE INTERNATIONAL INCTaiwanActive DMF 37975 · latest filing Apr 2023
- EUROAPI HUNGARY LTDHungaryActive DMF 11563 · latest filing Jul 1995
- Pharmacia & Upjohn, Inc.United StatesActive DMF 5202 · latest filing Jan 1984
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (2)
Certificates of Suitability on the EDQM register for Dinoprostone, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 3 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| TIEN (TIANJIN) PHARMACEUTICAL CO., LTD. Tianjin | CN | CEP 2025-371 - Rev 00 Dinoprostone | Nov 2026 | — |
| KYOWA PHARMA CHEMICAL CO., LTD. Takaoka | JP | CEP 2025-081 - Rev 00 Dinoprostone, Alternate Manufacturing Method | May 2025 | Inspected Dec 2024 Japan |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (1)
Organisations whose Type II DMFs for Dinoprostone are no longer active. These show a past filing, not current supply.
Show all 1 historical record
- Czechia · Inactive DMF 10621 · filed Dec 1993
Overview
Dinoprostone is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL548).
Chemical identity
- IUPAC name
- (Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid
- Canonical SMILES
- CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O)O
- InChIKey
- XEYBRNLFEZDVAW-ARSRFYASSA-N
- Synonyms
- Cervidil, Dinoprostona, Dinoprostone, Dinoprostone beta-cyclodextrin clathrate, Enzaprost e, Minprostin e2, NSC-165560, NSC-196514, Prepidil, Propess, Prostaglandin e2, Prostin e2
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Prostaglandin Analog
- Chemical structure
- Prostaglandins
Record history
Changes to current records between 13 Nov 2026 and 16 Nov 2026:
- + TIEN (TIANJIN) PHARMACEUTICAL CO., LTD. Tianjin CN now shows a valid CEP (EDQM holder)
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Dinoprostone?
5 organisations hold an active US FDA Type II Drug Master File or a CEP for Dinoprostone: KYOWA PHARMA CHEMICAL CO LTD (Japan), TIEN (Tianjin) Pharmaceutical Co. Ltd (China), CHIROGATE INTERNATIONAL INC (Taiwan), EUROAPI HUNGARY LTD (Hungary) and Pharmacia & Upjohn, Inc. (United States). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Dinoprostone Drug Master Files are active?
KYOWA PHARMA CHEMICAL CO LTD (DMF 41392, 11274), TIEN (Tianjin) Pharmaceutical Co. Ltd (DMF 42261), CHIROGATE INTERNATIONAL INC (DMF 37975), EUROAPI HUNGARY LTD (DMF 11563) and Pharmacia & Upjohn, Inc. (DMF 5202). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Dinoprostone records mean?
1 organisation has only inactive Type II DMFs for Dinoprostone. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Dinoprostone have a European Certificate of Suitability?
Yes. 2 organisations hold a valid CEP for Dinoprostone on the EDQM register, including TIEN (TIANJIN) PHARMACEUTICAL CO., LTD. Tianjin (CN) and KYOWA PHARMA CHEMICAL CO., LTD. Takaoka (JP). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Dinoprostone supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Dinoprostone?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.